Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study

References

• Aarthy, M., Kumar, D., Giri, R., & Singh, S. K. (2018). E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study. Gene, 658, 159–177. https://doi.org/https://doi.org/10.1016/j.gene.2018.03.026
   PubMed Web of Science ®Google Scholar
• Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science, 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
   PubMed Web of Science ®Google Scholar
• Ashburn, T. T., & Thor, K. B. (2004). Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews. Drug Discovery, 3(8), 673–683. https://doi.org/https://doi.org/10.1038/nrd1468
   PubMed Web of Science ®Google Scholar
• Battershill, P. E., & Clissold, S. P. (1989). Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs, 38(5), 658–702. . https://doi.org/https://doi.org/10.2165/00003495-198938050-00002
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1-3), 43–56. https://doi.org/https://doi.org/10.1016/0010-4655(95)00042-E
   Web of Science ®Google Scholar
• Breckenridge, A., & Jacob, R. (2019). Overcoming the legal and regulatory barriers to drug repurposing. Nature Reviews. Drug Discovery, 18(1), 1–2. https://doi.org/https://doi.org/10.1038/nrd.2018.92
   PubMed Web of Science ®Google Scholar
• Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C. … Wang, C. (2020). A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. The New England Journal of Medicine, 382(19), 1787–1799. https://doi.org/https://doi.org/10.1056/NEJMoa2001282
   PubMed Web of Science ®Google Scholar
• Cermelli, C., Cuoghi, A., Scuri, M., Bettua, C., Neglia, R. G., Ardizzoni, A., Blasi, E., Iannitti, T., & Palmieri, B. (2011). In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid. Virology Journal, 8(1), 141. https://doi.org/https://doi.org/10.1186/1743-422X-8-141
   PubMedGoogle Scholar
• Chandwani, A., & Shuter, J. (2008). Lopinavir/ritonavir in the treatment of HIV-1 infection: A review. Therapeutics and Clinical Risk Management, 4(5), 1023–1033. https://doi.org/https://doi.org/10.2147/TCRM.S3285
   PubMedGoogle Scholar
• (2020). COVID-19 ring-based prevention trial with lopinavir/ritonavir – Full text view – ClinicalTrials.gov. Retrieved April 29, 2020, from https://clinicaltrials.gov/ct2/show/NCT04321174
   Google Scholar
• David, C. C., & Jacobs, D. J. (2014). Principal component analysis: A method for determining the essential dynamics of proteins BT. In D. R. Livesay (Ed.), Protein dynamics: Methods and protocols (pp. 193–226). Totowa, NJ: Humana Press. https://doi.org/https://doi.org/10.1007/978-1-62703-658-0_11.
   Google Scholar
• Davidson, R. N., den Boer, M., & Ritmeijer, K. (2009). Paromomycin. Transactions of the Royal Society of Tropical Medicine and Hygiene, 103(7), 653–660. https://doi.org/https://doi.org/10.1016/j.trstmh.2008.09.008
   PubMed Web of Science ®Google Scholar
• DiNicolantonio, J. J., Bhutani, J., & O’Keefe, J. H. (2015). Acarbose: Safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open Heart, 2(1), e000327. https://doi.org/https://doi.org/10.1136/openhrt-2015-000327
   PubMed Web of Science ®Google Scholar
• Ennifar, E., Paillart, J.-C., Bodlenner, A., Walter, P., Weibel, J.-M., Aubertin, A.-M., Pale, P., Dumas, P., & Marquet, R. (2006). Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: From crystal to cell. Nucleic Acids Research, 34(8), 2328–2339. https://doi.org/https://doi.org/10.1093/nar/gkl317
   PubMed Web of Science ®Google Scholar
• Fraser, J. R. E., Laurent, T. C., & Laurent, U. B. G. (1997). Hyaluronan: Its nature, distribution, functions and turnover. Journal of Internal Medicine, 242(1), 27–33. https://doi.org/https://doi.org/10.1046/j.1365-2796.1997.00170.x
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., Mainz, D. T., Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Giri, R., Bhardwaj, T., Shegane, M., Gehi, B. R., Kumar, P., Gadhave, K., Oldfield, C. J., & Uversky, V. N. (2020). When darkness becomes a ray of light in the dark times: Understanding the COVID-19 via the comparative analysis of the dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses. BioRxiv, 2020.03.13.990598. https://doi.org/https://doi.org/10.1101/2020.03.13.990598.
   Google Scholar
• Halgren, T. A. (2009). Identifying and characterizing binding sites and assessing druggability. Journal of Chemical Information and Modeling, 49(2), 377–389. https://doi.org/https://doi.org/10.1021/ci800324m
   PubMed Web of Science ®Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. https://doi.org/https://doi.org/10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Web of Science ®Google Scholar
• Hofland, L. J., & Lamberts, S. W. J. (1996). Somatostatin receptors and disease: Role of receptor subtypes. Baillière’s Clinical Endocrinology and Metabolism, 10(1), 163–176. https://doi.org/https://doi.org/10.1016/S0950-351X(96)80362-4
   PubMedGoogle Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics, 55(2), 351–367. https://doi.org/https://doi.org/10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X. … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Khalili, J. S., Zhu, H., Mak, N. S. A., Yan, Y., & Zhu, Y. (2020). Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. Journal of Medical Virology, 92(7), 740–746. https://doi.org/https://doi.org/10.1002/jmv.25798
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577.
   Google Scholar
• Krilov, L. R. (2001). Respiratory syncytial virus: Update on infection, treatment, and prevention. Current Infectious Disease Reports, 3(3), 242–246. https://doi.org/https://doi.org/10.1007/s11908-001-0026-3
   PubMedGoogle Scholar
• Kumar, A., Liang, B., Aarthy, M., Singh, S. K., Garg, N., Mysorekar, I. U., & Giri, R. (2018). Hydroxychloroquine inhibits Zika virus NS2B-NS3 protease. ACS Omega., 3(12), 18132–18141. https://doi.org/https://doi.org/10.1021/acsomega.8b01002
   PubMed Web of Science ®Google Scholar
• Kumar, D., Aarthy, M., Kumar, P., Singh, S. K., Uversky, V. N., & Giri, R. (2020). Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery. Journal of Biomolecular Structure & Dynamics, 38(16), 4811–4827. https://doi.org/https://doi.org/10.1080/07391102.2019.1689851
   Web of Science ®Google Scholar
• Kumar, D., Sharma, N., Aarthy, M., Singh, S. K., & Giri, R. (2020). Mechanistic insights into Zika virus NS3 helicase inhibition by epigallocatechin-3-gallate. ACS Omega, 5(19), 11217–11226. https://doi.org/https://doi.org/10.1021/acsomega.0c01353
   PubMed Web of Science ®Google Scholar
• Kumar, P., Kumar, D., & Giri, R. (2019). Targeting the nsp2 cysteine protease of chikungunya virus using FDA approved library and selected cysteine protease inhibitors. Pathogens, 8(3), 128. https://doi.org/https://doi.org/10.3390/pathogens8030128
   PubMed Web of Science ®Google Scholar
• Kumar, P., Saumya, K. U., & Giri, R. (2020). Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of Mycobacterium tuberculosis. Journal of Biomolecular Structure & Dynamics, 38(17), 4917–4997. https://doi.org/https://doi.org/10.1080/07391102.2019.1696231
   Web of Science ®Google Scholar
• Kumar, Y., Singh, H., & Patel, C. N. (2020). In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Journal of Infection and Public Health, 13(9), 1210–1223. https://doi.org/https://doi.org/10.1016/j.jiph.2020.06.016
   PubMed Web of Science ®Google Scholar
• Li, J., Lim, S. P., Beer, D., Patel, V., Wen, D., Tumanut, C., Tully, D. C., Williams, J. A., Jiricek, J., Priestle, J. P., Harris, J. L., & Vasudevan, S. G. (2005). Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. The Journal of Biological Chemistry, 280(31), 28766–28774. https://doi.org/https://doi.org/10.1074/jbc.M500588200
   PubMed Web of Science ®Google Scholar
• Loustaud-Ratti, V., Debette-Gratien, M., Jacques, J., Alain, S., Marquet, P., Sautereau, D., Rousseau, A., & Carrier, P. (2016). Ribavirin: Past, present and future. World Journal of Hepatology, 8(2), 123–130. https://doi.org/https://doi.org/10.4254/wjh.v8.i2.123
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• McKeage, K., Cheer, S., & Wagstaff, A. J. (2003). Octreotide long-acting release (LAR): A review of its use in the management of acromegaly. Drugs, 63(22), 2473–2499. https://doi.org/https://doi.org/10.2165/00003495-200363220-00014
   PubMed Web of Science ®Google Scholar
• McMullan, B. J., & Mostaghim, M. (2015). Prescribing azithromycin. Australian Prescriber, 38(3), 87–90. https://doi.org/https://doi.org/10.18773/austprescr.2015.030
   PubMed Web of Science ®Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802.
   Web of Science ®Google Scholar
• Peters, D. H., Friedel, H. A., & McTavish, D. (1992). Azithromycin. Drugs, 44(5), 750–799. https://doi.org/https://doi.org/10.2165/00003495-199244050-00007
   PubMed Web of Science ®Google Scholar
• Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., Norris, A., Sanseau, P., Cavalla, D., & Pirmohamed, M. (2019). Drug repurposing: Progress, challenges and recommendations. Nature Reviews. Drug Discovery, 18(1), 41–58. https://doi.org/https://doi.org/10.1038/nrd.2018.168
   PubMed Web of Science ®Google Scholar
• Ramirez, M. S., & Tolmasky, M. E. (2017). Amikacin: Uses, resistance, and prospects for inhibition. Molecules, 22(12), 2267. https://doi.org/https://doi.org/10.3390/molecules22122267
   PubMed Web of Science ®Google Scholar
• Reddy, K. R., Nelson, D. R., & Zeuzem, S. (2009). Ribavirin: Current role in the optimal clinical management of chronic hepatitis C. Journal of Hepatology, 50(2), 402–411. https://doi.org/https://doi.org/10.1016/j.jhep.2008.11.006
   PubMed Web of Science ®Google Scholar
• (2020). Safety and efficacy of hydroxychloroquine associated with azithromycin in SARS-CoV2 virus (Coalition Covid-19 Brasil II) – Full text view – ClinicalTrials.gov. Retrieved April 29, 2020, from https://clinicaltrials.gov/ct2/show/NCT04321278
   Google Scholar
• Sang, P., Tian, S.-H., Meng, Z.-H., & Yang, L.-Q. (2020). Anti-HIV drug repurposing against SARS-CoV-2. RSC Advances, 10(27), 15775–15783. https://doi.org/https://doi.org/10.1039/D0RA01899F
   PubMed Web of Science ®Google Scholar
• Shalev-Benami, M., Zhang, Y., Rozenberg, H., Nobe, Y., Taoka, M., Matzov, D., Zimmerman, E., Bashan, A., Isobe, T., Jaffe, C. L., Yonath, A., & Skiniotis, G. (2017). Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin. Nature Communications, 8(1), 1589. https://doi.org/https://doi.org/10.1038/s41467-017-01664-4
   PubMedGoogle Scholar
• Sharma, N., Kumar, P., & Giri, R. (2020). Polysaccharides like pentagalloylglucose, parishin A and stevioside inhibits the viral entry by binding the Zika virus envelope protein. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1797538
   Google Scholar
• Sharma, N., Murali, A., Singh, S. K., & Giri, R. (2017). Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein. International Journal of Biological Macromolecules, 104(Pt A), 1046–1054. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2017.06.105
   PubMed Web of Science ®Google Scholar
• Shirley, M. (2019). Amikacin liposome inhalation suspension: A review in Mycobacterium avium complex lung disease. Drugs, 79(5), 555–562. https://doi.org/https://doi.org/10.1007/s40265-019-01095-z
   PubMed Web of Science ®Google Scholar
• Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012). Combination therapy for treatment of infections with gram-negative bacteria. Clinical Microbiology Reviews, 25(3), 450–470. https://doi.org/https://doi.org/10.1128/CMR.05041-11
   PubMed Web of Science ®Google Scholar
• U.S. National Library of Medicine. (2020). Evaluation of the efficacy of the hydroxychloroquine-azithromycin combination in the in the prevention of COVID-19 related SDRA – Full Text View – ClinicalTrials.gov. Retrieved April 29, 2020, from https://clinicaltrials.gov/ct2/show/NCT04347512
   Google Scholar
• Victorovich, K. V., Rajanish, G., Aleksandrovna, K. T., Krishna, K. S., Nicolaevich, S. A., & Vitoldovich, P. V. (2020). Translation-associated mutational U-pressure in the first ORF of SARS-CoV-2 and other coronaviruses. BioRxiv, 2020.05.05.078238. https://doi.org/https://doi.org/10.1101/2020.05.05.078238.
   Google Scholar
• Widjaja, L. K., Bora, M., Chan, P. N. P. H., Lipik, V., Wong, T. T. L., & Venkatraman, S. S. (2014). Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery applications. Journal of Biomedical Materials Research Part A, 102(9), 3056–3065. https://doi.org/https://doi.org/10.1002/jbm.a.34976
   PubMed Web of Science ®Google Scholar
• Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., … Wilson, M. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/https://doi.org/10.1093/nar/gkx1037
   PubMed Web of Science ®Google Scholar
• Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica. B, 10(5), 766–788. https://doi.org/https://doi.org/10.1016/j.apsb.2020.02.008
   PubMed Web of Science ®Google Scholar
• Yadav, R., Selvaraj, C., Aarthy, M., Kumar, P., Kumar, A., Singh, S. K., & Giri, R. (2020). Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from Zika virus through in-silico approaches. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2019.1709546.
   Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science, 368(6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar